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Humboldt-Universita¨t zu Berlin, GermanyABSTRACT The matrix protein M1 plays a pivotal role in the budding of influenza virus from the plasma membrane (PM) of
infected cells. This protein interacts with viral genetic material and envelope proteins while binding to the inner leaflet of the
PM. Its oligomerization is therefore closely connected to the assembly of viral components and the formation of new virions.
Of interest, the molecular details of M1 interaction with lipids and other viral proteins are far from being understood, and it re-
mains to be determined whether the multimerization of M1 is affected by its binding to the PM and interaction with its compo-
nents. To clarify the connection between M1 oligomerization and binding to lipid membranes, we applied a combination of
several quantitative microscopy approaches. First, we used number and brightness (N&B) microscopy to characterize protein
multimerization upon interaction with the PM of living cells. Second, we used controlled biophysical models of the PM (i.e., sup-
ported bilayers) to delve into the details of M1-lipid and M1-M1 interactions by employing a combination of raster image corre-
lation spectroscopy (RICS), fluorescence correlation spectroscopy (FCS), and atomic forcemicroscopy (AFM). Our results show
that M1 oligomer formation is strongly enhanced by membrane binding and does not necessarily require the presence of other
viral proteins. Furthermore, we propose a specific model to explain M1 binding to the lipid bilayer and the formation of multimers.INTRODUCTIONInfection by influenza virus is a major cause of mortality
around the world. All three influenza virus genera (A, B,
and C) belong to the Orthomyxoviridae family of enveloped
viruses (1), but only influenza A virus (IAV) is a primary
concern for human health. Its capsid is formed by a lipid
bilayer containing three membrane proteins: hemagglutinin
(HA), neuraminidase (NA), and the proton channel M2 (2).
The most abundant protein in the virus is matrix protein 1
(M1),which forms thematrix layer directlybelow the lipid en-
velope and binds the viral ribonucleoproteins (3). Therefore,
in a fully formed virion, M1 has the important function of sta-
bilizing thewhole three-dimensional (3D) structure of the en-
velope (4–6). Acting as an endoskeleton, the M1 shell might
provide anchoring points for viral membrane proteins (7–10).
In addition, M1 supposedly plays a key role during virion
assembly utilizing multiple protein-lipid and protein-protein
interactions (8). According to the current understanding, M1
is recruited and multimerizes at the plasma membrane (PM)
of an infected cell together with M2, HA, and NA at the site
of a nascent virion (8). The protein assembly process pro-
ceeds until the bilayer bends and a new viral particle is
formed and released. It is yet not clear whether M1 multime-
rization requires or is influenced by other viral components
(e.g., HA). However, it is known that M1 has the potential toSubmitted April 28, 2014, and accepted for publication June 24, 2014.
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other proteins. Zhang et al. (11) reported that M1 forms di-
mers and high-order multimers depending on the pH and
protein concentration. Small-angle x-ray scattering mea-
surements showed that M1 clusters in solution display an
architecture similar to that of authentic virions (12). Similar-
ities between large M1 assemblies in vitro and M1 structures
in isolated viruses have also been suggested by x-ray crys-
tallography studies (4). Furthermore, in certain cases the
expression of solely M1 is sufficient to produce virus-like
particles (13,14). These observations suggest that M1 multi-
merization has a central role in the process of new virion
formation. Therefore, understanding the details of M1-M1
interaction in a simple controlled system, in the absence
of other proteins, might shed light on the process of IAVas-
sembly. On one hand, it is known that M1 binds in vitro to
lipid bilayers containing phosphatidylserine (PS), probably
due to electrostatic interactions (15,16). On the other
hand, M1 in vivo targets internal cellular membranes (e.g.,
the Golgi and endoplasmic reticulum), but does not bind
preferentially to the inner leaflet of the PM (17–19), despite
its relatively high PS content (20). In either case, M1-M1
interaction and multimerization have not yet been explored
in connection to membrane binding, leaving unresolved
questions. More specifically, does the M1-lipid interaction
affect the multimerization process?
To address this question, we applied the number and
brightness (N&B) approach to monitor M1 multimerizationhttp://dx.doi.org/10.1016/j.bpj.2014.06.042
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model systems mimicking the PM, atomic force microscopy
(AFM), and quantitative fluorescence microscopy (i.e.,
raster image correlation spectroscopy (RICS) and fluores-
cence correlation spectroscopy (FCS)) to characterize M1-
M1 and M1-lipid interactions. Our results suggest a specific
molecular mechanism by which M1 can bind to lipid bila-
yers and form high-order multimers.MATERIALS AND METHODS
Chemicals
All lipids were purchased fromAvanti Polar Lipids (Alabaster, AL) and used
without further purification. Alexa Fluor 647 carboxylic acid succinimidyl
ester (A647) was acquired from Life Technologies (Darmstadt, Germany).
PBS, medium, and supplements for cell culture were purchased from PAN
Biotech (Aidenbach, Germany). The plasmid pET15b-M1 for the expression
of M1 derived fromA/FPV/Rostock/34 was kindly provided by Dr. N. Jung-
nick (Louisiana State University, Baton Rouge, LA). Bacto tryptone, Bacto
yeast extract, and Bacto agar were bought from BD (Heidelberg, Germany).
Ampicillin and chloramphenicol were purchased from Sigma Aldrich
(Taufkirchen, Germany) and Serva (Heidelberg, Germany). NaCl, NaOH,
and glucose were bought from Roth (Karlsruhe, Germany). Lysozyme,
CaCl2, bovine deoxyribonuclease I (DNase), and imidazole were purchased
from Sigma (Munich, Germany). Mercaptoethanol was bought from Merck
(Darmstadt, Germany) and cOmplete Ultra EDTA-free protease inhibitor
was bought fromRoche (Basel, Switzerland). Isopropyl-1-thio-b-D-galacto-
pyranoside (IPTG) was bought from Fermentas-Fisher Scientific (Schwerte,
Germany). The unsaturated lipid analog carrying three nitrilotriacetic acid
headgroups (NTA-lipid) for the binding of His-tagged proteins (21) was
a generous gift from Dr. J. Piehler (University of Osnabru¨ck, Osnabru¨ck,
Germany).Cell culture
Madin-Darby canine kidney (MDCK) cells were seeded in 35 mm glass-
bottom petri dishes 24 h before experiments were conducted, and allowed
to grow to 80% confluency in full growth medium (10% fetal calf serum).
The cells were transfected using TurboFect (Thermo Fisher Scientific,
Waltham, MA) according to the manufacturer’s protocol and used for
microscopy starting at 2–4 h posttransfection. M1 from Influenza A/FPV/
Rostock/34 was cloned into plasmid pEYFP-C1 (Clontech, Mountain
View, CA) yielding M1 with an N-terminal YFP tag (YFP-M1) or M1
with an N-terminal YFP tag and a C-terminal nuclear export signal
(YFP-M1-NES), as described previously (17). Both plasmids were kindly
provided by M. Veit and B. Thaa (Freie Universita¨t, Berlin, Germany).
The empty plasmid was used as a control.N&B analysis
N&B analysis was performed as described previously (22,23). Briefly,
confocal images were acquired on an inverted Olympus IX81 microscope
equipped with a FluoView FV1000 scan and confocal detection unit
(Olympus, Tokyo, Japan) coupled to a detection unit containing avalanche
photodiodes (PicoQuant, Berlin, Germany). The 488 nm excitation light
from a CW Argon laser (Showa Optronics, Tokyo, Japan) was focused
with a 60 UPLS Aprocromat 1.2 NA water objective into the sample.
The fluorescence signal passed through a 550/100 bandpass filter before
detection. The laser power was chosen so as to keep the photon count below
~1–2 MHz (i.e., typical values were%4 mW). Images of 128  128 pixels
were acquired with pixel dimensions of ~400 nm and a pixel dwell time of100 ms. Image time stacks of 100 scans were collected at time intervals
of 1.95 s per frame. The images were exported into ASCII files containing
the photon counts as a function of pixel position using the PicoQuant
SymPhoTime64 software. We then analyzed the time stacks using a self-
written MATLAB algorithm (The MathWorks, Natick, MA), implementing
the equations from Digman et al. (22) for the specific case of true photon-
counting detectors (23), and thus obtained the true molecular brightness
(hereafter referred to simply as brightness) as a function of pixel position.
Brightness maps were filtered with a cross median filter using a 3  3
neighborhood.
To correct for photobleaching effects and minor cell movements, we used
a boxcar filter with an eight-frame length as described previously (24).
Spurious events that led to extraneous fluctuations were automatically
excluded by the use of a cutoff threshold when average brightness values
were calculated during the boxcar filtering (i.e., excluding the 20% of
data points from top and bottom tails of the data set). We avoided saturation
of detectors leading to artifactual reduction of brightness by excluding im-
ages with pixels in which photon counting exceeded ~1–2 MHz (22). Using
this selection criterion, we kept the saturation-induced brightness decrease
below 10–20%. Finally, to further correct the weak residual negative corre-
lation between brightness and pixel intensity, we measured the detector
response using a reflective metal surface. The brightness-versus-intensity
plot (which should be constant and equal to 0 for all intensity values)
thus obtained was used to correct the actual experimental data (22).Protein purification
The plasmid pET15b-M1 was transformed into Rosetta E. coli (DE3)
pLysS-competent cells for expression of M1 with an N-terminal His6
tag. Cells were grown at 37C in a medium containing 0.4% glucose,
50 mg/mL chloramphenicol, and ampicillin to an OD600 of ~0.8. The culture
was harvested by centrifugation after induction with 0.1 mM IPTG at 37C
for 3 h. Then the cells were resuspended in lysis buffer (PBS, pH 7.4,
250 mM NaCl with 100 mg/mL DNase, 300 mg/mL lysozyme, 5 mM mer-
captoethanol, protease inhibitor cocktail, and 1 mM phenylmethylsulfonyl
fluoride) at 4C for 1 h and then lysed by sonication. Cellular membranes
and debris were removed by centrifugation at 90,000 g for 20 min at
4C. The supernatant was flowed through a chelating Talon matrix column
(Clontech, Saint-Germain-en-Laye, France) and M1 was purified according
to the manufacturer’s protocol. The equilibration and wash buffers were
PBS, 500 mM NaCl pH 7.0, and 5 mM mercaptoethanol. The intermediate
elution buffer was PBS, 500 mMNaCl pH 7.0, 5 mMmercaptoethanol, and
60 mM imidazole. The final elution buffer was PBS, 250 mM NaCl pH 7.0,
5 mM mercaptoethanol, and 250 mM imidazole. At this step, the typical
protein concentration was ~50 mM. After dilution to ~10 mM, the protein
was stored in the final elution buffer for up to 3 days at 4C. At the begin-
ning of each experiment, the sample was centrifuged for 5 min at 17,000 g
(4C) to remove any protein aggregate that might nevertheless have formed.
When needed, M1 was labeled with A647 succinimidyl ester to obtain
A647-M1. To this end, the protein was incubated with a 3-fold excess reac-
tive dye for 24 h at 4C (pH 7). Unbound dye was removed via gel filtration
(Sephadex G-25) and the protein was stored in the final elution buffer at
~5 mM concentration for up to 3 days at 4C. Due to the suboptimal labeling
conditions (i.e., pH 7 and protein concentration < 2 mg/mL), the typical
degrees of labeling ranged between ~0.1 and 0.3 A647 molecules per
M1. Note that a low M1 concentration and neutral pH were purposely
chosen to avoid the risk of protein aggregation.Supported lipid bilayers preparation
Supported lipid bilayers (SLBs) were prepared on glass coverslips using the
vesicle fusionmethod (25). Small unilamellar vesicleswere obtained by son-
ication. Egg phosphatidylcholine (ePC) and PS extracted from bovine brain
(bPS) were mixed in chloroform at different molar ratios. After solventBiophysical Journal 107(4) 912–923
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concentration and resuspended by vortexing. After sonication, 100 ml of
the suspensionwas deposited on a clean coverslip. The samplewas delimited
by a plastic cylinder of 7mmdiameter. AddingCaCl2 to a final concentration
of 3 mM induced vesicle fusion and the formation of a lipid bilayer. The
sample volume was brought to 200 mL and after a 30 min incubation it
was vigorously rinsed with PBS buffer to remove any unfused vesicle.
A647-M1 was added on top of the SLB from a ~5 mM stock solution
to a final concentration ranging from 1 to 150 nM. After 5 min, the sample
was rinsed five times with 200 mL PBS and directly imaged on the
microscope.Confocal microscopy, FCS, and RICS analysis
Confocal imaging, FCS, and RICS were performed on the same setup as
described in the N&B analysis section above. The 640 nm excitation light
from a pulsed diode laser (PicoQuant, Berlin, Germany) was focused with a
60UPLS Apocromat 1.2 NAwater objective into the sample. The fluores-
cence signal passed through a 650 nm longpass filter before detection. Im-
ages of 256  256 pixels were acquired with pixel dimensions of 54.8 nm
and a pixel dwell time of 12.5 ms. Image time stacks of 100 scans were
collected at time intervals of 1.155 s per frame (4.325 ms per line). Out-
of-plane fluorescence was reduced by a 100 mm pinhole in front of the de-
tector. For each sample, we performed a total of six measurements in
different positions: three time stacks using ~0.3 mW excitation power and
three time stacks using ~8 mW. In general, for each examined sample, a total
of 18 RICS measurements from three independent preparations were
collected. For the measurements performed at higher laser power, to avoid
bleaching artifacts, only one or two frames were analyzed. For the other
measurements, all 100 frames were averaged and analyzed. The images
were exported into ASCII files containing the photon counts as a function
of pixel position using the PicoQuant SymPhoTime64 software. We subse-
quently analyzed the time stacks using a self-written MATLAB algorithm,
implementing the equations from Digman et al. (26) for the 2D diffusion
case. The fitting of the spatial-temporal correlation function resulted in
three output parameters: the diffusion coefficient D, the lateral waist u0,
and the particle concentration C. Also, by calculating the total fluorescence
intensity for the first frame of each measurement, we could calculate parti-
cle brightness as the ratio between intensity and C. The parameters, which
should be independent of the laser power and protein degree of labeling
(i.e., D, C, and u0), were indeed comparable in measurements performed
with different laser powers and thus were simply pooled and averaged
from the 18 measurements for each sample. To take into account variations
in laser power and protein labeling efficiency, the other parameters (i.e.,
total fluorescence intensity and brightness) were normalized to the values
measured each day in a specific sample before averaging, as described in
the Results section.
The same optical setup was used to perform single-point FCS. For each
sample, a total of three independent protein preparations were measured at
different concentrations in the same buffer solution used for RICS experi-
ments on SLBs, using a laser power of ~0.7 mW. Each measure consisted
of a 60-s-long signal acquisition. The fluorescence signal time trace was
then divided into two or more segments, which were correlated and fitted
using the PicoQuantSymPhoTime64 software. To take into account varia-
tions in protein labeling efficiency, the calculated brightness values were
normalized for each independent preparation on the values measured for
the 50 nM M1 concentration sample. The diffusion time values were
normalized to the value measured each day for the diffusion of unconju-
gated A647 succinimidyl ester.AFM
For AFM, we prepared SLBs as described above, using a slightly modified
protocol. A glass coverslip was attached with UV-curing glue to a glassBiophysical Journal 107(4) 912–923slide to increase the mechanical stability of the sample, while maintaining
the same support surface used in fluorescence-based experiments. Due to
the dimensions of the AFM glass block, the total sample volume was
four times larger and therefore the total lipid amount used in the preparation
had to be correspondingly increased.
Before adding M1 at the required concentration, we tested for proper for-
mation of the SLB by AFM force measurements. Bilayer piercing experi-
ments were performed to ensure the presence of a single bilayer on the
surface (27), followed by incubation with M1 as described above. For every
M1 concentration, seven topography images at different positions from
three independent measurements were used for further analysis.
All AFM measurements were performed in PBS at pH 7 and 24C with a
NanoWizard III (JPK, Berlin, Germany) in AC mode using a triangular
shaped MLCT cantilever (Bruker, Camarillo, CA) with a nominal reso-
nance frequency of 38 kHz. For image analysis, JPK data-processing soft-
ware (JPK, Berlin, Germany) and MATLAB were employed.RESULTS
M1 forms multimers in proximity to the PM of
living MDCK cells
To study M1 multimerization in living cells, we expressed
a fluorescent YFP-M1 construct in MDCK cells. Fig. 1 A
shows a confocal microscopy image of two typical cells ex-
pressing fluorescent YFP-M1. The protein appears distrib-
uted all over the cell body and, in certain cases, enriched
in the perinuclear region, in line with previous observations
(17). Most importantly, no strong M1 binding to the PM can
be observed. Next, we used the N&B approach to measure
the brightness of YFP-M1 and hence its multimerization
state as a function of its position inside the cells. To this
end, we collected 100 frames from each sample (total mea-
surement time of ~2 min) and calculated the first and second
moments of the fluorescence fluctuation distribution for
each pixel. The N&B analysis thus provided spatial maps
of both the number and brightness of diffusing fluorescent
M1 molecules (either as monomers or multimeric com-
plexes). Multimeric protein complexes are characterized
by higher brightness. Fig. 1 B shows the brightness map ob-
tained for the same cells shown in Fig. 1 A. For comparison,
Fig. 1 C shows a typical brightness map obtained for cells
expressing soluble free YFP (see also Fig. S1 in the Support-
ing Material).
The spatial distribution of pixel brightness indicates that
M1 multimers (i.e., pixels with higher brightness values)
are localized preferentially in proximity to the PM. This
observation is specific to the expression of M1, since the
expression of YFP alone (used here as a control) results in
a more homogeneous brightness distribution (Fig. 1 C). To
quantitatively characterize this effect, we analyzed several
samples with cells expressing YFP-M1 or just YFP. First,
we manually divided each cell into two regions of interest
(ROIs): 1), a 5- to 10-pixel-thick stripe including the PM;
and 2), a roughly circular ROI including the nucleus and
most of the cytoplasm. Second, we identified the top 10%
pixels with the highest brightness values (referred to as
the brightest pixels) in the whole cell. Finally, we calculated
FIGURE 1 Confocal fluorescence imaging and
brightness mapping of YFP-M1 expressed in
living MDCK cells. (A) Confocal microscopy
fluorescence image of two typical MDCK cells
expressing YFP-M1. Other cells that are not ex-
pressing the fluorescent protein construct can
also be observed, probably due to a weak auto-
fluorescence signal. This image was obtained as
an average of 100 frames (128  128 pixels)
collected over ~2–3 min. (B) Pixel brightness
map obtained by applying N&B analysis to the
image shown in A. Some pixels that showed
out of range brightness outside the cells (e.g.,
due to bleaching of immobile proteins) were
removed. (C) Pixel brightness map for a typical
MDCK cell expressing soluble YFP. The corre-
sponding fluorescence intensity confocal micro-
scopy image is shown in Fig. S1. All images
were collected at 24C and scale bars are
8 mm. (D) Quantification of the intracellular
spatial distribution of bright pixels. The brightest
pixels are defined as the top 10% brightest pixels
in each cell. For each cell, an ROI enclosing the
PM and an ROI including the rest of the cell
were defined. Panel D shows the relative amount
of the brightest pixels found in the ROI enclosing
the PM, for all of the examined samples
(YFP-M1-NES (n ¼ 8), YFP-M1 (n ¼ 18), and soluble cytosolic YFP (n ¼ 10)). The YFP-M1 sample and the YFP sample are significantly different
(two-sample t-test, p < 0.01). Error bars represent standard deviations (SDs). To see this figure in color, go online.
M1-Lipid Interaction and Multimerization 915how many of these brightest pixels were included in the
ROI containing the PM. We applied this procedure to cells
expressing YFP-M1 (18 cells, three independent samples),
YFP (10 cells, three independent samples), or YFP-M1-
NES (i.e., a specific construct with enhanced export from
the nucleus (17); eight cells, one sample). The results in
Fig. 1 D show that M1 multimers, either the wild-type or
the NES construct, are reproducibly found in proximity to
the PM. On the other hand, YFP brightness does not signif-
icantly correlate with PM localization.
It is worth noting that a quantitative comparison of bright-
ness values (e.g., between Fig. 1, B and C) to precisely
determine the oligomerization state of M1 cannot be pro-
vided by this approach. For example, in the simple approx-
imation that few very large (i.e., very bright) M1 multimers
are formed on the PM, and M1 monomers diffuse in the
cytosol, the brightness value calculated for a single pixel
including the PM would be a weighted average brightness
of few multimers and many monomers (since the few-nano-
meters-thick PM occupies a very small volume fraction of a
400  400 nm2 pixel). Furthermore, to keep the total signal
intensity below a reasonable threshold suitable for sensitive
photon-counting detectors, cells with varying expression
levels had to be imaged with varying laser power. This im-
plies that the absolute brightness values (directly depending
on laser power) might vary slightly from measurement to
measurement. For the same reason, we waited only a few
hours after transfection and selected cells that displayed
low levels of protein expression. All of the examined cellshad a number of YFP-M1 molecules between ~102 and
4102 per pixel, as calculated using the N&B analysis
and averaging all over each cell. Cells with much higher
expression levels were excluded because the total fluores-
cence signal would have been too high for the photon-count-
ing detectors. The measured protein amount corresponds
to a concentration with an order of magnitude of ~10 mM,
assuming a pixel size of 400 nm  400 nm  1 mm.M1 multimerizes upon binding to PS-containing
model membranes
Once we had assessed the potential of M1 to form large mul-
timers in proximity to cellular PM, we delved into the de-
tails of M1-lipid and M1-M1 interactions in a well-defined
and controlled system. M1 was expressed in E. coli, puri-
fied, and fluorescently labeled as described in the Materials
and Methods section, yielding A647-M1. Typical protein
samples consisted of a ~1-3:10 A647-M1/M1 mixture
(i.e., between one and three out of 10 M1 molecules were
labeled). For the sake of simplicity, hereafter we will refer
to the mixture of unlabeled M1 and labeled M1 as just
A647-M1. The protein was then added at different concen-
trations (1–150 nM) to SLBs composed of ePC and 40 mol
% bPS. The amount of bPS was similar to that used in
previous studies (15). After 5 min, the unbound protein
was washed away. M1 did not bind irreversibly to the mem-
brane, as the protein could be at least partially removed
with further washing (data not shown). We used confocalBiophysical Journal 107(4) 912–923
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terize protein binding to the lipid bilayer and, at the same
time, M1 multimerization. Fig. 2 A shows a typical confocal
microscopy image of A647-M1 bound to the SLB. Further-
more, a RICS analysis of analogous fluorescence images
provided several parameters regarding the state of the bound
protein: fluorescence intensity (which is proportional to the
total amount of bound protein), diffusion coefficient, con-
centration, and brightness (which reports the multimeri-
zation state of the protein). Note that the parameters
calculated from a RICS analysis of such images (e.g., con-
centration) do not refer to single proteins bound to the mem-
brane, but rather to the independent fluorescent entities that
are diffusing as single objects on the bilayers. For example,
if M1 multimerized on the membrane, the calculated bright-
ness refers to the total brightness of the whole independently
diffusing protein complexes.
As expected, the total amount of protein bound to the
membrane increased monotonically with the concentration
of M1 in solution (~50-fold; data not shown). Fig. 2 B showsFIGURE 2 RICS analysis of M1 multimerization upon interaction with lipid
microscopy image of a typical sample consisting of an SLB made of ePC and 40
the average number of photons per pixel measured over 100 frames. Scale bar
concentration, and normalized brightness, respectively, as a function of protein
formed by setting the value measured for the 150 nM M1 sample to 100. Th
(i.e., A647-M1 concentration between 10 and 150 nM). Error bars represent SD
color, go online.
Biophysical Journal 107(4) 912–923that the diffusion coefficient D of membrane-bound A647-
M1 decreased 10-fold (from ~1.5 mm2/s to 0.1 mm2/s)
when the protein concentration in solution was increased
from 1 nM to 150 nM. Fig. 2 C reports the concentration
of M1 clusters on the bilayer, which decreased from ~20
to ~2 M1 clusters/mm2 (i.e., many small clusters change
into fewer (possibly larger) clusters) when the M1 concen-
tration in solution was increased from 1 to 10 nM. Above
10 nM, we did not observe further changes. Note that the
values obtained for 1 and 10 nM M1 in general are asso-
ciated with a larger statistical spread, simply due to the
low signal/noise ratio at such low protein concentrations.
Finally, Fig. 2 D shows the normalized brightness of the
clusters, calculated as the total fluorescence intensity of a
sample (proportional to the total amount of bound protein)
divided by the total number of clusters in each image.
This parameter therefore reports the degree of clustering
(or relative amount of M1 molecules per cluster) as a func-
tion of M1 concentration in solution. Brightness values were
normalized each day to the value measured for the 150 nMbilayers as a function of protein concentration. (A) Confocal fluorescence
mol % bPS after incubation with 50 nM A647-M1. The color scale indicates
is 50 pixels (2.7 mm). (B–D) Protein diffusion coefficient, particle/cluster
concentration during the binding step. Brightness normalization was per-
e inset in C shows the concentration measurements on a magnified scale
s of 18 measurements in three independent samples. To see this figure in
M1-Lipid Interaction and Multimerization 917M1 sample (i.e., 100%) to take into account variations in
laser power and the degree of protein labeling. Our data
show that when the A647-M1 concentration in solution
was increased from 1 to 150 nM, the molecular size of the
protein clusters on the membrane increased of a factor
~2  102 (i.e., from ~0.5 to 100). Further washing of the
sample did not significantly affect M1 multimer brightness
(data not shown).
It was previously shown that M1 multimers dissociate at
acidic pH (11). To verify that the brightness parameter re-
ported by RICS is indeed sensitive to M1 multimerization
similarly to other experimental approaches, we compared
the brightness of M1 clusters at pH 7 and pH 5. To this
end, we let M1 (50 nM) bind to an SLB as described above
at pH 7. After removing the unbound protein, we measured
the total bound protein (i.e., total fluorescence intensity) and
its brightness. Then, we changed the pH of the sample to 5
using a small volume of a 2 M pH 5 Na-Acetate buffer (6 ml
in a 200 ml sample). After 10 min and with no additional
washing step, we measured the same fluorescence parame-
ters. Our experiment showed only a marginal decrease in
the amount of A647-M1 bound to the membrane, but a
~3-fold decrease in brightness (Fig. S2).FIGURE 3 FCS measurements of A647-M1 diffusion and brightness
in solution as a function of protein concentration. (A and B) Normalized
brightness (A) and diffusion time (B) of A647-M1 in solution for increasing
protein concentration (i.e., from 50 to 300 nM). Brightness values were
normalized to what was measured for the 50 nM M1 sample. Diffusion
time values were normalized to what was measured for unconjugated
A647 in the same conditions. The dashed lines represent the unitary values
(e.g., the value relative to unconjugated A647 for B) as a reference. Error
bars are SDs (n ¼ 3).M1 does not multimerize in solution at nanomolar
concentrations
It is known that M1 tends to multimerize in solution at pH 7,
especially at concentrations abovez30 mM (11). Since the
focus of this study was the role of lipid membranes in deter-
mining M1-M1 interactions, it was important to control the
extent to which M1 multimers formed in solution before in-
teracting with lipid bilayers. For this purpose, we used FCS
to monitor the dynamics and brightness of A647-M1 in
buffer solution, in the absence of lipid membranes. More
in detail, we measured the ratio between average fluores-
cence intensity and number of molecules in the focal
volume, thus obtaining the brightness of the diffusing mol-
ecules (or molecular complexes). Fig. 3 A shows the values
obtained for different A647-M1 concentrations, normalized
to the brightness value measured (each day, for each inde-
pendent protein preparation) for the 50 nM M1 sample.
Our results show that protein brightness (i.e., multimeriza-
tion) did not increase in the concentration range in which
RICS detected extensive multimerization on lipid mem-
branes (50–150 nM), and up to 300 nM. It is worth noting
that a direct comparison between the brightness measured
for M1 in solution (Fig. 3 A) and that measured for M1
bound to membranes (Fig. 2 D) is not possible due to the
different experimental settings (i.e., laser power, sample
geometry, protein labeling efficiency, and fluorophore quan-
tum yield) used for FCS and RICS experiments.
Similarly to the brightness measurements, Fig. 3 B shows
that the dynamics of A647-M1 were not influenced by an
increasing protein concentration in solution in the absenceof lipids. The diffusion time of M1 (roughly corresponding
to the time needed to cross the FCS focal volume and
inversely proportional to the diffusion coefficient) remained
constant three to four times longer than the diffusion time of
unconjugated A647 succinimidyl ester (used here as a refer-
ence). Considering the molecular masses of A647 and a M1
monomer (i.e., ~1 kDa and ~30 kDa, respectively), our mea-
surements are compatible with M1 diffusing as monomers
or dimers (expected relative diffusion times of ~3.1 and
~3.9, respectively, compared with A647).M1 total binding to membrane does not
significantly affect protein multimerization
In the previous paragraphs, we have shown that increasing
M1 concentrations in solution are connected to higher
protein binding to the membrane and significant proteinBiophysical Journal 107(4) 912–923
918 Hilsch et al.multimerization. To assess whether M1 multimerization de-
pends directly on the extent of membrane binding, we de-
signed two different experiments in which we modulated
M1 binding to the lipid bilayer and monitored changes in
protein clustering.
It is known that M1 binds to lipid bilayers containing PS
(16). Therefore, we monitored M1 multimerization on bila-
yers containing different amounts of bPS. Fig. 4 A shows the
relative fluorescence signal (i.e., total protein binding) to
SLBs as a function of their bPS content. Our data show,
as expected, that M1 binding increases 2- to 3-fold when
bPS concentration in the membrane is increased from 0 to
40 mol %. According to our results, the M1-lipid interaction
is enhanced by (but does not require) the presence of PS.
Interestingly, Fig. 4 B shows that M1 cluster brightness in-
creases only ~20% (compared with, e.g., the 200-fold in-
crease shown in Fig. 2 D). To take into account variations
in laser power and degree of protein labeling, we normalized
the brightness and fluorescence intensity values each day to
the values measured for the 40 mol % bPS sample.
As a second approach, we produced SLBs containing
95 mol % ePC and 5 mol % of an unsaturated lipid analog
carrying three nitrilotriacetic acid groups (NTA-lipid).
NTA-lipids were shown to specifically bind His-tagged pro-
teins (21), such as the M1 used in this study. Fig. 4 C shows
that M1 binding to NTA-lipid containing SLBs was ~10
times higher compared with SLBs containing 5 mol %Biophysical Journal 107(4) 912–923bPS. As shown in Fig. 4 D, notwithstanding the dramatic
increase in protein binding caused by the presence of
NTA-lipids, M1 brightness (clustering) remained compara-
ble to that observed in samples with low protein binding,
such as SLBs containing 5 mol % bPS. Note that the large
spread in brightness values observed for the latter sample
derives from the low signal/noise ratio due to limited pro-
tein binding. Brightness and fluorescence intensity values
were normalized each day to the values measured for the
NTA-lipid containing samples. The diffusion coefficient of
A647-M1 bound to the membrane did not vary significantly
between NTA and 5 mol % bPS containing samples or
among samples with varying amounts of bPS (data not
shown).AFM reveals concentration-dependent clustering
of unlabeled M1
All of the experiments described thus far required labeling
of M1 either with a fluorescent protein (see N&B experi-
ments) or with a small fluorophore (see experiments with
A647-M1). Furthermore, the above-mentioned optical mi-
croscopy measurements are characterized by a spatial reso-
lution that ultimately is limited by the size of the point
spread function. For example, RICS experiments have a
spatial resolution of ~300 nm. To overcome these limita-
tions, we performed AFM measurements of M1 bound toFIGURE 4 RICS analysis of M1 multimeriza-
tion as a function of total protein binding. (A)
Normalized total fluorescence intensity measured
for A647-M1 (50 nM) bound to SLBs with varying
bPS concentration. (B) Normalized brightness
measured for the same samples as in A. The data
in both A and B were normalized by setting the
values measured for the sample containing
40 mol % bPS to 100. (C) Normalized total fluores-
cence intensity measured for A647-M1 (50 nM)
bound to SLBs containing 95 mol % ePC and
either 5 mol % NTA-lipid or 5 mol % bPS. (D)
Normalized brightness measured for the same sam-
ples as in C. The data in bothC andDwere normal-
ized by setting the values measured for the sample
containing 5 mol % NTA-lipid to 100. The data
sets shown for the two samples in D are not statis-
tically distinguishable (two-sample t-test, p >
0.05). Error bars represent SDs of 18 measure-
ments in three independent samples.
M1-Lipid Interaction and Multimerization 919SLBs containing 40 mol % bPS. M1 and bPS concentrations
were chosen in the range used for the RICS experiments
shown in Fig. 2, i.e., 10 and 50 nM.
Fig. 5, A and B, show typical topographical images of the
lipid membrane surface after M1 binding (10 and 50 nM,
respectively) and the subsequent removal of unbound pro-
tein. Samples incubated with 10 nM M1 already show a
considerable degree of protein binding. The membrane sur-
face is uniformly covered by objects of heterogeneous
lateral shape and width, but with a well-defined height of
2.5 5 0.6 nm (Fig. S3). Before exposure to the protein,
the SLB surface appears flat and homogeneous within the
sensitivity of the instrument, with only rare exceptions
(Fig. S4). Therefore, it can be safely concluded that the fea-
tures observed in Fig. 5 are indeed constituted of M1 mole-
cules. Upon an increase in M1 concentration, fewer but
higher objects can be observed (Fig. 5 B). Their average
diameter is 935 37 nm (including only the objects higher
than 10 nm), with the exception of some elongated struc-
tures up to ~1 mm long. Most importantly, M1 multimers
observed in the 50 nM sample are up to ~10–20 times higher
than those observed in the 10 nM M1 sample. M1 structures
with a height of ~2.5 nm are also present in the 50 nM M1
samples in varying amounts, but cannot be easily observed
with the zoom needed to visualize the larger protein clusters
shown in Fig. 5 B.
Fig. 5 C shows the observed frequency distribution of
pixels with heights of 5–40 nm, calculated from an average
of seven images from three independent preparations for
each protein concentration. First, we calculated the pixel
height histograms over the whole height range measured
in the sample (see Fig. S5 for a representative 10 nM M1
sample). Such histograms are dominated by a large peak
around 0 nm, representing the surface of the bilayer. A sec-
ond peak can also be observed that originates from the pres-
ence of the M1 structures with a height of ~2.5 nm. To
characterize large M1 clusters that formed at a 50 nM M1
concentration and occupied a relatively small fraction ofFIGURE 5 AFM imaging of M1 bound to PS-containing bilayers. (A and B)
treatment with 10 and 50 nM M1, respectively. As described for the previous ex
extensive washing. The color code refers to the measured height and is the same
ability (n ¼ 7 images from three independent preparations), referring to the freq
with 10 nM M1 (red) or 50 nM M1 (black). To see this figure in color, go onlithe image, we subtracted the 0 nm peak and plotted only
the data between 5 and 40 nm. Fig. 5 C clearly shows that
larger M1 multimers (e.g., with height > 20 nm) are
observed much more frequently on SLBs incubated with
50 nm M1 than on those incubated with just 10 nM M1.DISCUSSION
M1 is the most abundant protein in IAVand it plays a pivotal
role in the viral life cycle (3) because it is fundamentally
important during the assembly of new virions from the
PM of infected cells (14). According to recent hypotheses
(28), M1 coordinates the assembly of viral components at
the PM by binding 1), IAV genetic material; 2), lipids in
the inner leaflet of the PM; 3), IAV transmembrane proteins;
and 4), other M1 molecules to eventually form the 3D struc-
ture underlying the envelope. The delicate balance of pro-
tein-protein and protein-lipid interactions in a nascent
virion and the precise role of M1 in regulating this process
are still far from being understood. For example, although
M1 was shown to have the capability to form biologically
relevant structures in solution by itself (4,12), it is yet not
clear whether interactions with other viral proteins are
needed for M1 multimerization during viral bud formation.
In vivo experiments have provided contrasting results
regarding the capability of M1 expressed in cells to form vi-
rus-like-particles in the absence of other viral components
(13,14,29). More generally, it was clearly shown that M1
can bind membranes containing negatively charged lipids
(e.g., PS) (15), but no data are available regarding the
connection between M1 binding to lipids and its multimeri-
zation, either in vivo or in vitro.M1 forms multimers upon interaction with lipid
membranes
Recent advances in quantitative fluorescence microscopy
have provided powerful tools for studying protein-proteinAFM topographical images of ePC bilayers containing 40 mol % bPS after
periments, the protein was incubated with the membrane for 5 min before
for both panels. Scale bars are 2 mm. (C) Average height occurrence prob-
uency of observed heights between 5 and 40 nm for membranes incubated
ne.
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N&B analysis has been used to study the self-association
of transmembrane receptors (24), membrane-associated
proteins (23), and Ebola virus assembly (31). Similarly,
we have investigated M1 self-association in MDCK cells
expressing a fluorescent construct of the protein, YFP-M1.
In line with previous observations (17), wild-type M1 asso-
ciated mainly with the nucleus and perinuclear regions,
whereas M1-NES accumulated in the cytoplasm and partic-
ularly at the Golgi apparatus and the endoplasmic reticulum.
The lack of a specific membrane-targeting region might be
responsible for the weak association with the PM (19). Our
results strikingly show that in spite of the limited association
with the PM, M1 could indeed form multimers in regions
adjacent to the PM. The observed spatial multimerization
pattern is specific to M1, since a control performed with sol-
uble YFP displayed a uniform brightness/multimerization
distribution in the cell body. This finding clearly suggests
a connection between M1-lipid interaction at the PM and
M1 multimerization. Interestingly, the YFP-M1 concentra-
tions in our experiments were comparable to the physiolog-
ical concentrations of M1 in infected cells (z10 mM). An
upper estimate for the M1 concentration in cells can be
calculated assuming 3  103 M1 molecules per virus (32),
up to 103–104 viruses per cell (33) and a cell volume of
~1 pL (103 mm3).
Although N&B experiments on living cells can
provide information about protein-protein interactions in
a physiologically relevant context, they are limited by the
complexity of the examined system itself. The presence of
cellular proteins in the cytosol or PM components might
in fact influence M1-M1 and M1-lipid interactions. Further-
more, N&B analysis cannot distinguish clusters of proteins
diffusing in the plane of the PM from several M1 monomers
bound to a single membrane vesicle in proximity of the PM.
In both cases, N&B analysis would report an increase
in brightness. To dissect the interaction between M1 and
lipid membranes, and how it influences protein multimeriza-
tion, we complemented our investigation by using model
membranes in well-defined experimental conditions.
Similar to what was observed in cells, we detected the for-
mation of M1 multimers bound to the lipid bilayer. First, we
observed that the amount of boundM1 depended on the pres-
ence and amount of negatively charged lipids in the mem-
brane (e.g., PS), as previously shown (15), and on the
amount of protein in solution. Second, we observed that the
amount of protein interactingwith themembrane determined
the size of M1 clusters. The correlation betweenM1 concen-
tration and clustering efficiency was measured by image
correlation spectroscopy (i.e., RICS) and AFM. When the
M1 concentration was increased from 1 to 150 nM, we
observed a decrease of the diffusion coefficient from ~1.5
to ~0.5 mm2/s, i.e., from values typical of a single lipid-
anchored protein (34) to values typical of 102- to 103-nm-
radius lipid assemblies (35) diffusing in the plane of a liquidBiophysical Journal 107(4) 912–923membrane. Furthermore, we noticed that the number of clus-
ters reached a constant value of ~2 mm1 already at 10 nM.
Finally, a direct measurement of cluster brightness displayed
an increase of 2 orders of magnitude. These three observa-
tions strongly suggest that already at 10 nM M1 concentra-
tion, the membrane is almost covered with M1 oligomers.
This finding was directly confirmed by AFM measurements
showing that the surface of the lipid bilayers was extensively
covered with M1 at a 10 nM protein concentration. The
height of the observed protein structures (~2.5 nm higher
than the bilayer surface) suggests at least partial penetration
of M1 into the membrane, since the N-terminal monomer
fragment was determined to be 3  4  3 nm3 (4,36).
Increasing protein concentration does not affect the degree
towhich the bilayer is covered, but rather the size of the clus-
ters, which are then characterized by high brightness and
slow diffusion. This was observed with both wild-type
unlabeled proteins (using AFM) and fluorescently labeled
proteins. The combination of the two approaches is particu-
larly beneficial in this case because optical methods are
limited to a resolution of few hundred nanometers (AFM
measurements clearly indicate a size for such clusters of
~100 nm in diameter and up to ~35 nm in height).We believe
that these larger clusters observedviaAFM in the 50 nMsam-
ples are most probably the same protein structures observed
in fluorescence measurements (e.g., Fig. 2). Such protein as-
semblies behave as expected for M1 structures in vivo; for
example, they become unstable when the pH is lowered
from 7 to 5 (Fig. S2). Interestingly, pH-dependent weakening
of the M1-M1 interaction was also observed in virions (37)
and for M1 in solution (i.e., not bound to lipid membranes
(11)). Furthermore, the M1 assemblies we observed seemed
to be closely related to the structures detected in solution at
higher concentration (i.e., > ~30 mM) in previous studies
(12), as suggested by the similarities in size. On the other
hand, to our knowledge, the flat 2.5-nm-high M1 oligomers
(which were more evident in the 10 nM samples; Figs. 6 A
and S3) have not been observed before. Previous AFM inves-
tigations reported a different M1 lateral organization, but,
importantly, those measurements were not performed on
lipid membranes (12). Whether the flat oligomers we
observed are simply the precursors for the larger aggregates
or are distinct structures with physiological relevance re-
mains to be determined. To that end, we are currently per-
forming AFM measurements with higher magnification/
resolution in our laboratory.M1 dimers bind to the membrane and
subsequently form high-order multimers
Both the RICS (Fig. 2) and AFM data show that M1 forms
multimers on the surface of the lipid membrane, ranging in
size from a few to ~103molecules. The latter number is calcu-
lated considering the large cluster size roughly estimated
from AFM images (i.e., ~100 nm diameter and up to
FIGURE 6 Different binding models for M1 forming multimers on lipid
bilayers. Experimental evidence indicates that M1 monomers (or dimers),
shown as single red particles on the left side of each panel, form multimers
on the membrane surface (right side). (A) Formation of multimers might
occur before interaction with the lipids. (B) Alternatively, M1 might first
bind as monomer (or dimer) to the membrane and eventually cluster with
the already bound protein due to increased local concentration and more
likely lateral interaction. (C) Finally, M1 might first bind to the membrane
as a monomer (or dimer) and subsequently interact with the remaining pro-
tein in solution to form larger clusters. M1 and lipids are not drawn to scale.
To see this figure in color, go online.
M1-Lipid Interaction and Multimerization 921~30 nm in height) and from an estimate of M1 monomer size
(i.e., ~55 nm3 (12)). Since the technical approaches described
in this work have a limited time resolution (e.g., several sec-
onds for RICS), it is not possible to determine the temporal
order of events during M1 binding and multimerization. Inother words, the RICS and AFM results (Figs. 2 and 5,
respectively) are compatible with at least all of the different
binding modalities shown in the cartoons in Fig. 6.
One possibility is that M1 multimerizes quickly in solu-
tion and only after clustering binds to the membrane
(Fig. 6 A). However, this scenario would be difficult to
reconcile with the current understanding of IAV assembly
in infected cells, according to which new virions are formed
also via interaction between M1 and the other viral proteins
that are already in the PM (i.e., HA, NA, and M2) (8). Alter-
natively, M1 could bind to the membrane in large amounts,
at first without multimerizing (Fig. 6 B). The passage of M1
from solution to the 2D surface of the lipid bilayer would
then correspond to an effective increase in local concentra-
tion, according to the principle of dimensionality reduction
(38). This in turn would result in increased protein-protein
lateral interaction and thus multimerization. Finally, it might
be possible that M1 binds to the membrane and then acts as
clustering seed for further M1 molecules recruited from so-
lution (Fig. 6 C). Therefore, we designed specific experi-
ments to test the different models.
To investigate the likelihood of the scenario depicted in
Fig. 6 A, we performed FCS measurements of M1 diffusion
and brightness in solution as a function of protein concentra-
tion. These experiments were conducted in exactly the
same buffered solution used for the membrane binding
and clustering measurements (e.g., the experiments shown
in Fig. 2), with the only difference being the absence of
lipids in the sample. FCS measurements indicated that M1
is probably in either monomeric or dimeric form in solu-
tions, and no clustering was observed in the absence of
membranes for an M1 concentration < 300 nM. This is in
complete agreement with recent work showing that M1 is
a dimer in solution if the protein concentration is lower
than 0.1 mg/mL (3.4 mM) (11), as well as our N&B results
indicating that M1 multimerizes specifically in proximity
to the PM (rather than in the cytoplasm, for example). The
study of Zhang et al. (11) also indicated that the smallest
oligomerization state of M1 at neutral pH is a dimer. It is
therefore safe to assume that M1 in our experiments (i.e.,
the FCS measurements in Fig. 3 and RICS measurements
at the lowest concentrations in Fig. 2) is also in a dimeric
state. Thus, our FCS experiments rule out the model sug-
gesting M1 multimerization in solution followed by subse-
quent binding of M1 clusters to the membrane (Fig. 6 A).
To verify whether high protein surface density (as a
consequence of M1 binding and dimensionality reduction)
might enhance M1 multimerization, we purposely increased
protein binding to the bilayer. This experiment was specif-
ically designed to test the model presented in Fig. 6 B. Mod-
ulation of protein-membrane binding was achieved by
changing the amount of PS in the bilayer (Fig. 4, A and B)
or by using artificial lipids with high affinity to the His
tag included in the purified M1 (Fig. 4, C and D). In either
case, we observed only a minor correlation between totalBiophysical Journal 107(4) 912–923
922 Hilsch et al.M1 binding to the membrane and the degree of protein clus-
tering. This observation suggests that increased M1 surface
density on the bilayer (Fig. 6 B) does not play an essential
role in determining protein multimerization.
In conclusion, the results we obtained by RICS, AFM,
and FCS indicate that M1 binds to the membrane at first
probably as a dimer and eventually multimerizes when its
concentration in solution is above ~10 nM. Multimer growth
seems to occur mostly via interaction between already
bound M1 and M1 that are still in solution (see Fig. 6 C).
The situations depicted in Fig. 6, B and C, are not neces-
sarily mutually exclusive, but our results do not support
the hypothesis that lateral M1-M1 interactions play a major
role. Of interest, the model described in Fig. 6 B implies that
a higher amount of M1 expression in an infected cell might
be required (compared with the model described in Fig. 6 C)
to reach sufficiently high surface concentrations at the PM
and trigger M1 multimerization. Such a requirement would
probably lower the efficiency of the viral reproduction
process. On the other hand, we speculate that the preferen-
tial interaction between unbound M1 and lipid-bound M1
(rather than that between lipid-bound M1 molecules, for
example) might derive from the protein-lipid interaction
itself. Once bound to the bilayer, M1 might undergo a
conformational change or, for example, stably expose a
side that favors interaction with unbound M1 molecules.
In fact, ongoing circular dichroism spectroscopy experi-
ments in our laboratory suggest that the M1-lipid interaction
is accompanied by secondary structure rearrangements
(N. Jungnick and S.C., unpublished data). This issue will
be further explored in future studies.CONCLUSIONS
The experiments described in this work demonstrate the ten-
dency of M1 to form high-order multimers when interacting
with PS-containing lipid membranes, in the absence of other
proteins. Similarly, two recent studies described the forma-
tion of M1 self-assemblies that also formed spontaneously
(although in the absence of lipid membranes and at concen-
trations ~100 times higher than those used in this study)
(11,12). Our data provide for the first time, to our knowl-
edge, information about the role of lipid membranes in the
process of M1 multimerization. This information is particu-
larly interesting in a biological context because M1 suppos-
edly multimerizes at the PM of infected cells (8). According
to our results, the M1-M1 interaction is triggered and
enhanced by the presence of the lipid membrane already
at nanomolar concentrations. M1 dimer binding to the sur-
face of the bilayer is followed by further binding of the pro-
tein still in solution and the formation of large complexes
(see Fig. 6 C).
How precisely the M1 structures reported by us and other
groups are directly connected to those that form during IAV
assembly in vivo will be subject of further investigation. ForBiophysical Journal 107(4) 912–923example, the protein concentrations that we explored in our
work were 2–3 orders of magnitude lower than that calcu-
lated for the in vivo case. Although this observation might
suggest that the M1-lipid interaction is strong and that
IAV assembly might require very small amounts of M1 to
be initiated, it is important to note that IAV assembly in
the cellular environment is far more complex. In a living
cell, both the cytoplasm and the PM are crowded with pro-
teins and other biological macromolecules (39) that could
interfere with the above-mentioned M1-lipid interaction. It
is also possible that M1 assembly at the PM is modulated
in particular by the presence of spike proteins, e.g., through
interactions between M1 and the cytosolic moieties of HA
or NA. The model systems and the technical approaches
described in this work will most probably provide an oppor-
tunity to investigate these intriguing possibilities.SUPPORTING MATERIAL
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